Top

Published in:

01-08-2014 | Literatur kommentiert

Erhöht die hypofraktionierte Strahlentherapie bei Mammakarzinom die kardiale Letalität innerhalb von 20 Jahren?

Authors: Juliane Rieber, Prof. Dr. Klaus Herfarth

Published in: Strahlentherapie und Onkologie | Issue 8/2014

Auszug

Tjessem KH, Johansen S, Malinen E et al (2013) Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys 87:337–343 …

AWMF (2012) Interdisziplinäre S 3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms

Darby SC, Mcgale P, Taylor CW et al (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300†000 women in US SEER cancer registries. Lancet Oncol 6:557–565PubMedCrossRef

Group FT (2011) First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 100:93–100CrossRef

Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086–1094PubMedCrossRef

Hooning MJ, Botma A, Aleman BMP et al (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99:365–375PubMedCrossRef

Marhin W, Wai E, Tyldesley S (2007) Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 69:483–489PubMedCrossRef

Nilsson G, Holmberg L, Garmo H et al (2012) Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol 30:380–386PubMedCrossRef

Poortmans Psh KC, Budach V, Maingon P et al (2013) Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage I to III breast cancer: 10 years results of the EORTC radiation oncology and breast cancer groups phase III trial 22922/10925. EJC 2013 47(suppl 2)

Smith BD, Bentzen SM, Correa CR et al (2011) Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 81:59–68PubMedCrossRef

10.

Whelan Tjoi AI, Chapman JW, Chua B et al (2011) NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol, ASCO Annual Meeting Proceed (post-meeting edition) vol 29

11.

Tjessem KH, Johansen S, Malinen E et al (2013) Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys 87:337–343 (Originalbeitrag)

Title: Erhöht die hypofraktionierte Strahlentherapie bei Mammakarzinom die kardiale Letalität innerhalb von 20 Jahren?
Authors: Juliane Rieber
Prof. Dr. Klaus Herfarth
Publication date: 01-08-2014
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 8/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-014-0684-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Erhöht die hypofraktionierte Strahlentherapie bei Mammakarzinom die kardiale Letalität innerhalb von 20 Jahren?

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 8/2014

Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy

Risikoadaptierte intraoperative gezielte Radiotherapie versus Ganzbrustbestrahlung bei Mammakarzinompatientinnen

Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom

Radioprotection of normal tissue cells

Erratum to: Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial

Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer